G378X‐I148T CFTR variant: A new complex allele in a cystic fibrosis newborn with pancreatic insufficiency

G378X‐I148T CFTR variant: A new complex allele in a cystic fibrosis newborn with pancreatic insufficiency

Bibliographic Details
Main Authors:	Vito Terlizzi, Claudia Centrone, Matteo Botti, Giovanni Taccetti
Format:	Article
Language:	English
Published:	Wiley 2022-09-01
Series:	Molecular Genetics & Genomic Medicine
Online Access:	https://doi.org/10.1002/mgg3.2033

Similar Items

Cystic fibrosis in Tuscany: evolution of newborn screening strategies over time to the present
by: Matteo Botti, et al.
Published: (2021-01-01)

Impact of Pancreatitis-Associated Protein on Newborn Screening Outcomes and Detection of CFTR-Related Metabolic Syndrome (CRMS)/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A Monocentric Prospective Pilot Experience
by: Chiara Bianchimani, et al.
Published: (2022-08-01)

Non pathological sweat test, pancreatic insufficiency and Cystic Fibrosis: an unusual case in a child with F508del-duplication of exons 1–3 CFTR genotype
by: Vito Terlizzi, et al.
Published: (2024-11-01)

Clinical and Genotypical Features of False-Negative Patients in 26 Years of Cystic Fibrosis Neonatal Screening in Tuscany, Italy
by: Giovanni Taccetti, et al.
Published: (2020-07-01)

Dornase alfa in Cystic Fibrosis: indications, comparative studies and effects on lung clearance index
by: Vito Terlizzi, et al.
Published: (2022-08-01)

Hypertonic saline in people with cystic fibrosis: review of comparative studies and clinical practice
by: Vito Terlizzi, et al.
Published: (2021-08-01)

Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients.
by: Serena Schippa, et al.
Published: (2013-01-01)

CFTR modulators response of S737F and T465N CFTR variants on patient-derived rectal organoids
by: Karina Kleinfelder, et al.
Published: (2024-09-01)

Correction: Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Allelic Variants Relate to Shifts in Faecal Microbiota of Cystic Fibrosis Patients
Published: (2013-01-01)

Correction: Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Allelic Variants Relate to Shifts in Faecal Microbiota of Cystic Fibrosis Patients.
by: Serena Schippa, et al.
Published: (2013-01-01)

Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis
by: Giuseppe Fabio Parisi, et al.
Published: (2022-05-01)

ANDROLOGY EXAMINATION OF PATIENTS WITH PANCREATIC-SUFFICIENT AND PANCREATIC-INSUFFICIENT CYSTIC FIBROSIS
by: S. A. Repina, et al.
Published: (2018-08-01)

Comparison between Gibson–Cooke and Macroduct Methods in the Cystic Fibrosis Neonatal Screening Program and in Subjects Who Are Cystic Fibrosis Screen-Positive with an Inconclusive Diagnosis
by: Daniela Dolce, et al.
Published: (2023-07-01)

Cystic fibrosis transmembrane conductance regulator (CFTR)-targeted therapeutics for cystic fibrosis
by: Veselu, D-F, et al.
Published: (2024)

Clinical features and outcomes of persons with cystic fibrosis and nocardia isolation: a systematic review
by: Vito Terlizzi, et al.
Published: (2024-09-01)

Cystic Fibrosis and Oxidative Stress: The Role of CFTR
by: Evelina Moliteo, et al.
Published: (2022-08-01)

The Cystic Fibrosis Transmembrane Regulator (CFTR) in the kidney
by: MARCELO M. MORALES, et al.
Published: (2000-09-01)

CFTR and Ca2+ signaling in cystic fibrosis
by: Fabrice eAntigny, et al.
Published: (2011-10-01)

Strategies to circumvent the CFTR defect in cystic fibrosis
by: Frederic eBecq, et al.
Published: (2013-08-01)

Not All Is CFTR – Neutrophils and Cholesterol in Cystic Fibrosis
by: Stefano Castellani, et al.
Published: (2017-10-01)

Nutritional Status and Circulating Levels of Fat-Soluble Vitamins in Cystic Fibrosis Patients: A Cohort Study and Evaluation of the Effect of CFTR Modulators
by: Michela Francalanci, et al.
Published: (2023-01-01)

Considerations for the use of inhaled antibiotics for Pseudomonas aeruginosa in people with cystic fibrosis receiving CFTR modulator therapy
by: Barry J Plant, et al.
Published: (2024-07-01)

Comprehensive semen examination in patients with pancreatic-sufficient and pancreatic-insufficient cystic fibrosis
by: Anna O Sedova, et al.
Published: (2023-01-01)

Newborn Screening Quality Assurance Program for CFTR Mutation Detection and Gene Sequencing to Identify Cystic Fibrosis
by: Miyono M. Hendrix MS, et al.
Published: (2016-08-01)

Inflammation and CFTR: Might Neutrophils be the Key in Cystic Fibrosis?
by: V. Witko-Sarsat, et al.
Published: (1999-01-01)

Cross‐talk between CFTR and sphingolipids in cystic fibrosis
by: Dorina Dobi, et al.
Published: (2023-09-01)

Nutritional impact of CFTR modulators in children with cystic fibrosis
by: Margaux Gaschignard, et al.
Published: (2023-03-01)

Challenges in the treatment of cystic fibrosis in the era of CFTR modulators
by: Caroline Jacoby Schmidt, et al.
Published: (2024-05-01)

Clinical characteristics and outcome of SARS –CoV-2 infection in patients with cystic fibrosis managed at home
by: V. Terlizzi, et al.
Published: (2022-03-01)

Unilateral temporary diaphragmatic paralysis secondary to bronchial artery embolization in a girl with cystic fibrosis and massive hemoptysis: a case report
by: V. Terlizzi, et al.
Published: (2020-02-01)

Clinical development of triple-combination CFTR modulators for cystic fibrosis patients with one or two F508del alleles
by: Jennifer L. Taylor-Cousar, et al.
Published: (2019-06-01)

Effect of Dornase Alfa on the Lung Clearance Index in Children with Cystic Fibrosis: A Lesson from a Case Series
by: Vito Terlizzi, et al.
Published: (2022-10-01)

Mechanisms of CFTR functional variants that impair regulated bicarbonate permeation and increase risk for pancreatitis but not for cystic fibrosis.
by: Jessica LaRusch, et al.
Published: (2014-07-01)

Elexacaftor/tezacaftor/ivacaftor and inflammation in children and adolescents with cystic fibrosis: a retrospective dual-center cohort study
by: Angela Pepe, et al.
Published: (2025-02-01)

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitylation as a Novel Pharmaceutical Target for Cystic Fibrosis
by: Ryosuke Fukuda, et al.
Published: (2020-04-01)

A new era of cystic fibrosis therapy with CFTR modulators
by: Laura Gomes Boabaid de Barros, et al.
Published: (2025-01-01)

Impact of CFTR modulators on exercise capacity in adolescents with cystic fibrosis
by: Molla Imaduddin Ahmed, et al.
Published: (2024-02-01)

CFTR High Expresser Cells in cystic fibrosis and intestinal diseases
by: Diego Carlos dos Reis, et al.
Published: (2023-03-01)

The effect of CFTR modulators on structural lung disease in cystic fibrosis
by: L. Clara Mok, et al.
Published: (2023-04-01)

Molecular chaperones as targets to circumvent the CFTR defect in cystic fibrosis
by: Rebecca A Chanoux, et al.
Published: (2012-07-01)